Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Huaping Dai

Showing results (151-160 of 173) with videos related to

Pageof 18
Sort By:
BMJ Open|November 6, 2025
Fibrotic Interstitial Lung Disease Early Recognition and Strategic Therapy Study in China (FIRST): protocol for a prospective, multicentre registry studyShiyao Wang, Xinran Zhang, Bingbing Xie, et al.
Chest|September 18, 2025
Developing and Validation of a Multimodal-Based Machine Learning Model for Diagnosis of Usual Interstitial Pneumonia: A Prospective Multicenter StudyHongyi Wang, Anqi Liu, Yifei Ni, et al.
Chinese Medical Journal Pulmonary and Critical Care Medicine|April 13, 2026
Progression of interstitial lung abnormalities and its impact on mortality in patients with lung cancer resectionRuolin Mao, Haoyun Zhang, Qing Chang, et al.
Chinese Medical Journal|July 18, 2023
Clinical characteristics of hypersensitivity pneumonitis: non-fibrotic and fibrotic subtypesXueying Chen, Xiaoyan Yang, Yanhong Ren, et al.
Stem Cell Research & Therapy|October 8, 2024
Optimized administration of human embryonic stem cell-derived immunity-and-matrix regulatory cells for mouse lung injury and fibrosisDingyun Song, Zhongwen Li, Faguo Sun, et al.
Cell|December 24, 2019
Progressive Pulmonary Fibrosis Is Caused by Elevated Mechanical Tension on Alveolar Stem CellsHuijuan Wu, Yuanyuan Yu, Huanwei Huang, et al.
Frontiers in Medicine|November 25, 2022
Blood monocyte counts as a prognostic biomarker and predictor in Chinese patients with idiopathic pulmonary fibrosisXinran Zhang, Yanhong Ren, Bingbing Xie, et al.
The Journal of Experimental Medicine|January 14, 2015
Blocking follistatin-like 1 attenuates bleomycin-induced pulmonary fibrosis in miceYingying Dong, Yan Geng, Lian Li, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 2, 2020
Targeting FSTL1 for Multiple Fibrotic and Systemic Autoimmune DiseasesXiaohe Li, Yinshan Fang, Dingyuan Jiang, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|December 15, 2024
Diagnosis of Fibrotic Interstitial Lung Diseases Based on the Combination of Label-Free Quantitative Multiphoton Fiber Histology and Machine LearningWenzhuo Qiu, Qingyang Wang, Ying Zhang, et al.
Pageof 18

Showing results (151-160 of 173) with videos related to

Sort By:
Pageof 18
BMJ Open|November 6, 2025
Fibrotic Interstitial Lung Disease Early Recognition and Strategic Therapy Study in China (FIRST): protocol for a prospective, multicentre registry studyShiyao Wang, Xinran Zhang, Bingbing Xie, et al.
Chest|September 18, 2025
Developing and Validation of a Multimodal-Based Machine Learning Model for Diagnosis of Usual Interstitial Pneumonia: A Prospective Multicenter StudyHongyi Wang, Anqi Liu, Yifei Ni, et al.
Chinese Medical Journal Pulmonary and Critical Care Medicine|April 13, 2026
Progression of interstitial lung abnormalities and its impact on mortality in patients with lung cancer resectionRuolin Mao, Haoyun Zhang, Qing Chang, et al.
Chinese Medical Journal|July 18, 2023
Clinical characteristics of hypersensitivity pneumonitis: non-fibrotic and fibrotic subtypesXueying Chen, Xiaoyan Yang, Yanhong Ren, et al.
Stem Cell Research & Therapy|October 8, 2024
Optimized administration of human embryonic stem cell-derived immunity-and-matrix regulatory cells for mouse lung injury and fibrosisDingyun Song, Zhongwen Li, Faguo Sun, et al.
Cell|December 24, 2019
Progressive Pulmonary Fibrosis Is Caused by Elevated Mechanical Tension on Alveolar Stem CellsHuijuan Wu, Yuanyuan Yu, Huanwei Huang, et al.
Frontiers in Medicine|November 25, 2022
Blood monocyte counts as a prognostic biomarker and predictor in Chinese patients with idiopathic pulmonary fibrosisXinran Zhang, Yanhong Ren, Bingbing Xie, et al.
The Journal of Experimental Medicine|January 14, 2015
Blocking follistatin-like 1 attenuates bleomycin-induced pulmonary fibrosis in miceYingying Dong, Yan Geng, Lian Li, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 2, 2020
Targeting FSTL1 for Multiple Fibrotic and Systemic Autoimmune DiseasesXiaohe Li, Yinshan Fang, Dingyuan Jiang, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|December 15, 2024
Diagnosis of Fibrotic Interstitial Lung Diseases Based on the Combination of Label-Free Quantitative Multiphoton Fiber Histology and Machine LearningWenzhuo Qiu, Qingyang Wang, Ying Zhang, et al.
Pageof 18